Skip to main content
Top
Published in: Endocrine 2/2016

01-05-2016 | Endocrine Imaging

Trimodal 18F-DOPA PET/CT/MR fusion imaging for optimal restaging of head and neck paragangliomas in a SDHD mutation carrier

Authors: Giorgio Treglia, Teresa Ruberto, Luca Giovanella

Published in: Endocrine | Issue 2/2016

Login to get access

Excerpt

A 31-year-old female patient, carrier of succinate dehydrogenase subtype D (SDHD) gene mutation, who underwent resection of bilateral head and neck paragangliomas (HNPGLs) 4 years before, performed trimodal 18F-DOPA positron emission tomography (PET)/contrast-enhanced computed tomography (ceCT)/magnetic resonance (MR) fusion imaging for restaging, due to a suspicious relapse of disease in the right head and neck region at previous CT without contrast enhancement. …
Literature
2.
go back to reference J.P. Brito, N. Asi, M.R. Gionfriddo, C. Norman, A.L. Leppin, C. Zeballos-Palacios et al., The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review. Endocrine (2015). doi:10.1007/s12020-015-0544-7 J.P. Brito, N. Asi, M.R. Gionfriddo, C. Norman, A.L. Leppin, C. Zeballos-Palacios et al., The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review. Endocrine (2015). doi:10.​1007/​s12020-015-0544-7
3.
go back to reference G. Treglia, F. Cocciolillo, C. de Waure, F. Di Nardo, M.R. Gualano, P. Castaldi et al., Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur. J. Nucl. Med. Mol. Imaging 39, 1144–1153 (2012)CrossRefPubMed G. Treglia, F. Cocciolillo, C. de Waure, F. Di Nardo, M.R. Gualano, P. Castaldi et al., Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur. J. Nucl. Med. Mol. Imaging 39, 1144–1153 (2012)CrossRefPubMed
Metadata
Title
Trimodal 18F-DOPA PET/CT/MR fusion imaging for optimal restaging of head and neck paragangliomas in a SDHD mutation carrier
Authors
Giorgio Treglia
Teresa Ruberto
Luca Giovanella
Publication date
01-05-2016
Publisher
Springer US
Published in
Endocrine / Issue 2/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0589-7

Other articles of this Issue 2/2016

Endocrine 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.